The burden of depression in prostate cancer
- 12 August 2011
- journal article
- research article
- Published by Wiley in Psycho‐Oncology
- Vol. 21 (12), 1338-1345
- https://doi.org/10.1002/pon.2032
Abstract
Objective We sought to analyze the prevalence and incremental burden of depression among elderly with prostate cancer. Methods We adopted a retrospective cohort design using the Surveillance, Epidemiology and End Results-Medicare linked database between 1995 and 2003. Patients with prostate cancer diagnosed between 1995 and 1998 were identified and followed retrospectively for 1 year pre-diagnosis and up to 8 years post diagnosis. In this cohort of patients with prostate cancer, depression during treatment phase (1 year after diagnosis of prostate cancer) or in the follow-up phase was identified using the International Classification of Diseases-Ninth Revision depression-related codes. Poisson, general linear (log-link) and Cox regression models were used to determine the association between depression status during treatment and follow-up phases and outcomes–health resource utilization, cost and mortality. Results Of the 50,147 patients newly diagnosed with prostate cancer, 4285 (8.54%) had a diagnosis of depression. A diagnosis of depression during treatment phase was associated with higher odds of emergency room visits (odds ratio (OR) = 4.45, 95% CI = 4.13, 4.80), hospitalizations (OR = 3.22, CI = 3.08, 3.37), outpatient visits (OR = 1.71, CI = 1.67, 1.75) and excess risk of death over the course of the follow-up interval (hazard ratio = 2.82, CI = 2.60, 3.06). Health care costs associated with depression remained elevated compared with costs for men without depression, over the course of the follow-up. Conclusions Depression during the treatment phase was associated with significant health resource utilization, costs and mortality among men with prostate cancer. These findings emphasize the need to effectively identify and treat depression in the setting of prostate cancer. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Cancer Institute (5RO3CA 121338-02, 5P30AG031043-03, 2K24MH070407-06)
- National Institutes of Health
This publication has 51 references indexed in Scilit:
- The Chronology of Distress, Anxiety, and Depression in Older Prostate Cancer PatientsThe Oncologist, 2009
- Impact of Cancer on Health-Related Quality of Life of Older AmericansJNCI Journal of the National Cancer Institute, 2009
- Evaluation of Trends in the Cost of Initial Cancer TreatmentJNCI Journal of the National Cancer Institute, 2008
- Prospective study of depression and fatigue in men with advanced prostate cancer receiving hormone therapyPsycho‐Oncology, 2007
- Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-upBritish Journal of Cancer, 2006
- Psychological Functioning Associated with Prostate Cancer: Cross-Sectional Comparison of Patients Treated with Radiotherapy, Brachytherapy, or SurgeryJournal of Pain and Symptom Management, 2005
- Psychosocial consequences of prostate cancer: 30 years of researchGeriatric Nursing, 2005
- Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions.Health Psychology, 2003
- Depression in Men Receiving Androgen Deprivation Therapy for Prostate Cancer: A Pilot StudyPsycho‐Oncology, 2002
- Administrative Data for Public Health Surveillance and PlanningAnnual Review of Public Health, 2001